Prior to joining Kirkland, Stephanie was involved in the following matters:
- Lumine Group Inc. in its pending acquisition of Synchronoss Technologies, Inc.
- Qatalyst Partners as financial advisor to Coursera, Inc. in its acquisition of Udemy, Inc.
- Special Committee of Bumble Inc. in connection with its Tax Receivable Agreement (TRA) buyout
- Special Committee of Clearwater Analytics Holdings, Inc. in connection with its Tax Receivable Agreement (TRA) buyout
- MeridianLink, Inc. in its $2 billion sale to Centerbridge Partners, L.P.
- Olo Inc. in its $2 billion sale to Thoma Bravo, L.P.
- Teleflex in its acquisition of the vascular intervention business from Biotronik SE & co. KG
- Kronos Bio Inc. in its sale to Concentra Biosciences
- Vigil Neuroscience, Inc. in its $470 million sale to Sanofi SA
- Brightcove Inc. in its $233 sale to Bending Spoons S.p.A
- Societal CDMO, Inc. in its $130 million sale to CoreRx, Inc.
- Phoenix Biotech Acquisition Corp. in its merger with CERo Therapeutics, Inc.
- Harpoon Therapeutics, Inc. in its $680 million sale to Merck Sharp & Dohme LLC
- Renesas Electronics Corporation in its pending $339 million acquisition of Transphorm, Inc.
- Orchard Therapeutics, Inc. in its $477 million sale to Kyowa Kirin Co., Ltd
- Magenta Therapeutics, Inc. in its merger with Dianthus Therapeutics, Inc.
- EQRx, Inc. in its $1.1 billion sale to Revolution Medicines, Inc.
- TCR2 Therapeutics, Inc. in its $103 million sale to Adaptimmune Therapeutics plc
- Forma Therapeutics, Inc. in its $1.1 billion sale to Novo Nordisk
- Morningside Venture Investment Limited in its acquisition of Stealth BioTherapeutics Corp.
- Frazier Lifesciences Acquisition Corporation in its merger with NewAmsterdam Pharma Holding B.V.
- KVH Industries, Inc. in its $55 million sale of its inertial navigation business to EMCORE Corporation
- BioDelivery Sciences International in its $605 million sale to Collegium Pharmaceutical, Inc.
- Retail Properties of America in its $7.5 billion sale to Kite Realty Group Trust
- Leaf Group in its $323 million sale to Graham Holdings Company
- Neos Therapeutics, Inc. in its sale to Aytu BioScience, Inc.
- Xeris Pharmaceuticals, Inc. in its $267 million merger with Strongbridge Biopharma plc
- Special Committee of NantKwest in NantKwest’s merger with ImmunityBio, Inc.
- MyoKardia in connection with its $13.1 billion sale to Bristol-Myers Squibb Company
